FCM

Farallon Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Farallon Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$16M	Hold	2,122,262	–	–	0.07%	70
2025 Q1	$11.7M	Buy	2,122,262 +14,000	+0.7%	+$77.3K	0.06%	66
2024 Q4	$12.1M	Hold	2,108,262	–	–	0.05%	72
2024 Q3	$21.8M	Buy	2,108,262 +13,262	+0.6%	+$137K	0.1%	68
2024 Q2	$27.2M	Hold	2,095,000	–	–	0.12%	62
2024 Q1	$36.6M	Buy	2,095,000 +70,000	+3%	+$1.22M	0.16%	57
2023 Q4	$19.1M	Buy	2,025,000 +150,000	+8%	+$1.41M	0.09%	68
2023 Q3	$20.9M	Hold	1,875,000	–	–	0.1%	70
2023 Q2	$40.1M	Buy	1,875,000 +325,000	+21%	+$6.96M	0.2%	70
2023 Q1	$62.7M	Hold	1,550,000	–	–	0.34%	55
2022 Q4	$72.1M	Hold	1,550,000	–	–	0.43%	54
2022 Q3	$80.4M	Hold	1,550,000	–	–	0.44%	58
2022 Q2	$73.3M	Hold	1,550,000	–	–	0.4%	62
2022 Q1	$110M	Sell	1,550,000 -23,829	-2%	-$1.7M	0.53%	46
2021 Q4	$118M	Sell	1,573,829 -421,171	-21%	-$31.5M	0.59%	40
2021 Q3	$113M	Hold	1,995,000	–	–	0.53%	48
2021 Q2	$87.8M	Hold	1,995,000	–	–	0.36%	55
2021 Q1	$98.4M	Buy	1,995,000 +220,000	+12%	+$10.9M	0.49%	47
2020 Q4	$74.7M	Hold	1,775,000	–	–	0.45%	50
2020 Q3	$81.3M	Buy	1,775,000 +25,000	+1%	+$1.14M	0.56%	48
2020 Q2	$87.9M	Hold	1,750,000	–	–	0.7%	41
2020 Q1	$90M	Hold	1,750,000	–	–	0.77%	32
2019 Q4	$108M	Buy	1,750,000 +475,788	+37%	+$29.4M	0.73%	33
2019 Q3	$76.6M	Buy	1,274,212 +314,212	+33%	+$18.9M	0.58%	40
2019 Q2	$81M	Buy	960,000 +20,000	+2%	+$1.69M	0.53%	41
2019 Q1	$89.8M	Buy	940,000 +15,000	+2%	+$1.43M	0.68%	39
2018 Q4	$65.5M	Buy	925,000 +57,500	+7%	+$4.07M	0.48%	39
2018 Q3	$74.1M	Sell	867,500 -207,500	-19%	-$17.7M	0.44%	41
2018 Q2	$125M	Buy	1,075,000 +160,000	+17%	+$18.5M	0.77%	30
2018 Q1	$74M	Sell	915,000 -10,000	-1%	-$809K	0.51%	38
2017 Q4	$54.3M	Buy	925,000 +512,667	+124%	+$30.1M	0.44%	40
2017 Q3	$19.3M	Buy	+412,333	New	+$19.3M	0.17%	57